Asian Spectator


The Times

.

Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board

  • Written by PR Newswire Asia - Asian Spectator
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
  • RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerability to date.
  • Dr. Coulie brings more than 25 years of international biopharma leadership and deep expertise in pulmonary disease to the Atisama Board of Directors.

MELBOURNE, Australia, May 15, 2026 /PRNewswire/ -- Atisama Therapeutics (formerly...

Magazine

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

hacklink hack forum hacklink film izle hacklink z-libraryesim senegalbetparkbetparktelegram下载zlibrary bookscasino en ligneWPS下载IND RUMMYnon gamstop casinosnon gamstop casinos uknon gamstop casinoscasinos not on gamstopcasinos not on gamstopnon gamstop casinoonline gamblinguk casinosuk casinosStreamEastStreamEastjojobetmeritkingcashnow.imweb.mecasibomcasibomnakitbahisnakitbahismatbetnakitbahisjojobet